Confidence rating | Pre-WS mean (SD) | Post-WS mean (SD) | pvalue |
---|---|---|---|
Prophylactic indomethacin | 2.13 (0.99) | 2.53 (1.13) | 0.14 |
Treatment of symptomatic PDA | 2.20 (0.86) | 2.60 (0.99) | 0.06 |
Decision of PDA ligation | 1.87 (0.83) | 2.40 (0.99) | 0.02 |
Monitoring during indomethacin administration (e.g., signs and complications) | 2.60 (0.91) | 2.73 (0.80) | 0.41 |
Other PDA treatments (e.g., transfusion, diuretics) | 2.00 (0.76) | 2.33 (0.82) | 0.03 |
PDA treatments in chronic phase | 1.87 (0.99) | 2.20 (0.77) | 0.21 |
Fluid management during PDA treatments | 2.20 (0.94) | 2.47 (0.83) | 0.16 |
Respiratory management during PDA treatments | 2.13 (0.74) | 2.47 (0.83) | 0.06 |
Nutrition during PDA treatments | 2.27 (0.88) | 2.47 (0.99) | 0.32 |
Overall | 2.14 (0.76) | 2.47 (0.80) | 0.02 |
Sheffield Peer Review Assessment Tool | Â | Â | Â |
Good clinical care | 4.11 (0.56) | 4.49 (0.76) | 0.03 |
Maintain good medical practice | 3.95 (0.52) | 4.36 (0.77) | 0.03 |
Teaching and training | 4.10 (0.99) | 4.43 (0.92) | 0.04 |
Relationship with patients | 4.67 (0.77) | 4.89 (0.97) | 0.08 |
Working relationships with colleagues | 4.13 (0.36) | 4.43 (0.73) | 0.09 |
Overall | 4.14 (0.42) | 4.50 (0.71) | 0.05 |